Ultimovacs to Launch Phase II Combination Trial of UV1 in Lung Cancer (NSCLC)

By
Justin.choi
-
0
11
Ultimovacs ASA announced that the company’s universal cancer vaccine, UV1, will be investigated in a new Phase II clinical trial in combination with pembrolizumab in NSCLC.
[Ultimovacs ASA]

Sorry, but the selected Zotpress account can't be found.

Press Release